Empower Pharmacy’s GHK-Cu Facial Serum page is a pharmacy product record. That role matters: a listing for a compounded preparation does not necessarily include a clinical consultation, an all-in patient price or the same support arrangement as an online prescribing service.
We checked the official product page on October 5, 2026. It identifies a 503A pharmacy pathway, a 30 g preparation and several listed strengths. This review describes that public record without placing an order, verifying a patient-specific prescription or inspecting pharmacy operations.
Who prescribes, who dispenses and which charge belongs to each service?
The strength list belongs to a prescription decision
The Empower page lists GHK-Cu Facial Serum at 0.5%, 1% and 2%, with a 30 g quantity. Those are catalog options, not a recommendation that a reader choose a strength independently or switch between them according to a review-site score.
The page also distinguishes general dosing information from individualized prescription instructions. This review does not reproduce an application schedule as advice. The actual label and responsible prescribing professional determine how a supplied preparation should be used.
The percentage guide is useful because a strength list can tempt readers to rank products numerically. The concentration does not identify the complete base, resolve personal suitability or establish that one prescription would produce a better outcome than another.
Pharmacy and prescribing roles should not be merged
A reader may encounter Empower through a separate clinical provider. The pharmacy’s product page does not establish the terms of every provider relationship, and a provider’s price does not automatically reveal the pharmacy’s separate charge. Ask who is responsible for assessment, dispensing, payment and follow-up in the selected arrangement.
No public patient price for the complete GHK-Cu pathway was confirmed in this review. We therefore do not create a monthly amount from another pharmacy product or from a different prescriber’s quote. The cost guide explains how to request an itemized record when several organizations may be involved.
Defy Medical provides a useful contrast because its article describes access through a provider. AgelessRx publishes its own cream and first-month care offer. These are related subjects, but they are not interchangeable records of the same transaction.
A compounded serum remains a compounded drug
FDA explains that compounded drugs are not FDA-approved and do not undergo the agency’s approval review for safety, effectiveness and quality before marketing. Listing a preparation through a 503A pharmacy does not itself make the finished serum an FDA-approved product.
Ask for the exact ingredient record and dispensing label, including quantity, storage directions and applicable dates. A pharmacy’s general quality statement is relevant background, but it does not substitute for information about the preparation a particular person receives. This publication has not audited a batch or verified the formula analytically.
The distinction also affects comparison with a retail serum. A cosmetic ingredient list and a patient-specific prescription record are different documents. Neither should be replaced by the other simply because both use copper-peptide terminology.
Mechanism information is not a promised result
The Empower page explains GHK-Cu’s proposed biological roles and cites supporting material. A mechanism discussion can help identify why an ingredient is studied, but it does not establish a guaranteed cosmetic outcome from every dispensed serum. Formulation, context and the outcome measured remain relevant.
The post-laser study referenced elsewhere in this index concerns a particular treatment setting. It is not a head-to-head test of current pharmacy preparations or online care services. Our evidence guide explains why a source should not be stretched beyond that setting.
A reader should also distinguish a manufacturer or pharmacy’s discussion of possible adverse effects from an individual assessment. This article cannot diagnose a reaction, establish tolerance or tell someone to change the amount used. Those questions belong with the prescriber or pharmacist responsible for the actual product.
The next useful document is a complete quote and label
Empower’s page is valuable for identifying named strengths, quantity and the pharmacy context. The remaining purchase questions concern the clinical pathway, all required charges and the preparation that would actually be supplied. Keeping those documents together prevents a product listing from being mistaken for a complete care subscription.
Use the workbench to contrast this record with Likeness Firming Cream, whose public page combines a preparation description with recurring billing. The differences in format, available information and provider role are the substance of the comparison; an invented universal ranking would conceal them.
Sources & further reading
Commercial sources establish what a seller publishes. They do not independently verify its results. Browse the source library.
- Empower Pharmacy — GHK-Cu Facial SerumOfficial provider information · checked 2026-10-05. A pharmacy product record is distinct from a prescribing service or all-in care plan. Published claims and offer observations, not independent formulation or service testing.
- FDA — Understanding the risks of compounded drugsRegulatory guidance · checked 2026-09-26. Explains that compounded drugs are not FDA-approved and the agency does not review their safety, effectiveness, or quality before marketing.
- Effects of topical copper tripeptide complex on CO2 laser-resurfaced skin (2006)Published randomized study · checked 2026-09-26. Abstract retrieved through Europe PMC / MEDLINE. Thirteen completers; post-laser setting. Objective between-group improvements were not significant; patient satisfaction favored GHK-Cu. Not a study of the products reviewed here.